Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 3.73
-0.267 %
$ 491 M
Market Cap
-0.73
P/E
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands.[ Read More ]
The intrinsic value of one CGC stock under the base case scenario is HIDDEN Compared to the current market price of 3.73 USD, Canopy Growth Corporation is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart CGC
FINANCIALS
297 M
REVENUE
-229 M
OPERATING INCOME
-484 M
NET INCOME
-282 M
OPERATING CASH FLOW
242 M
INVESTING CASH FLOW
-465 M
FINANCING CASH FLOW
63 M
REVENUE
-45.9 M
OPERATING INCOME
-161 M
NET INCOME
-67.8 M
OPERATING CASH FLOW
-7.86 M
INVESTING CASH FLOW
88.9 M
FINANCING CASH FLOW
Balance Sheet Decomposition
Canopy Growth Corporation
| Current Assets | 371 M |
| Cash & Short-Term Investments | 203 M |
| Receivables | 51.8 M |
| Other Current Assets | 116 M |
| Non-Current Assets | 929 M |
| Long-Term Investments | 180 M |
| PP&E | 320 M |
| Other Non-Current Assets | 429 M |
| Current Liabilities | 235 M |
| Accounts Payable | 28.7 M |
| Short-Term Debt | 119 M |
| Other Current Liabilities | 86.9 M |
| Non-Current Liabilities | 565 M |
| Long-Term Debt | 549 M |
| Other Non-Current Liabilities | 16.2 M |
EFFICIENCY
Earnings Waterfall
Canopy Growth Corporation
| Revenue | 297 M |
| Cost Of Revenue | 216 M |
| Gross Profit | 80.9 M |
| Operating Expenses | 309 M |
| Operating Income | -229 M |
| Other Expenses | 255 M |
| Net Income | -484 M |
RATIOS
27.22%
GROSS MARGIN
-76.97%
OPERATING MARGIN
-221.19%
NET MARGIN
-131.36%
ROE
-50.55%
ROA
-21.38%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Canopy Growth Corporation
| Net Income | -484 M |
| Depreciation & Amortization | 53.2 M |
| Capital Expenditures | -4 M |
| Stock-Based Compensation | 14.2 M |
| Change in Working Capital | 0 |
| Others | 122 M |
| Free Cash Flow | -286 M |
Wall Street Analysts Price Targets
Canopy Growth Corporation
Wall Street analysts predict an average 1-year price target for CGC of $17.7 , with forecasts ranging from a low of $8 to a high of $35 .
CGC Lowest Price Target
Wall Street Target
8 USD
114.48%
CGC Average Price Target
Wall Street Target
17.7 USD
373.86%
CGC Highest Price Target
Wall Street Target
35 USD
838.34%
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
Canopy Growth Corporation
Sold
0-3 MONTHS
939 K USD 7
3-6 MONTHS
224 K USD 6
6-9 MONTHS
0 USD 0
9-12 MONTHS
127 K USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
1 month ago
Sep 30, 2024
|
Sell 9.88 K USD
|
Kruh Willy
Director |
- 1995
|
4.95 USD |
|
1 month ago
Sep 30, 2024
|
Sell 9.84 K USD
|
Yanofsky Theresa
Director |
- 1987
|
4.95 USD |
|
1 month ago
Sep 30, 2024
|
Sell 9.88 K USD
|
Mongeau Luc
Director |
- 1995
|
4.95 USD |
|
1 month ago
Sep 30, 2024
|
Sell 14.8 K USD
|
Lazzarato David Angelo
Director |
- 2993
|
4.95 USD |
|
2 months ago
Aug 22, 2024
|
Sell 335 K USD
|
Klein David Eric
Chief Executive Officer |
- 40135
|
8.35 USD |
|
2 months ago
Aug 22, 2024
|
Sell 140 K USD
|
Gedeon Christelle
See Remarks |
- 16788
|
8.35 USD |
|
2 months ago
Aug 22, 2024
|
Sell 419 K USD
|
Hong Judy Eun Joo
Chief Financial Officer |
- 50188
|
8.35 USD |
|
4 months ago
Jun 28, 2024
|
Sell 12.7 K USD
|
Yanofsky Theresa
Director |
- 1983
|
6.41 USD |
|
4 months ago
Jun 28, 2024
|
Sell 12.9 K USD
|
Mongeau Luc
Director |
- 2012
|
6.41 USD |
|
4 months ago
Jun 28, 2024
|
Sell 19.1 K USD
|
Lazzarato David Angelo
Director |
- 2986
|
6.41 USD |
|
4 months ago
Jun 28, 2024
|
Sell 12.9 K USD
|
Kruh Willy
Director |
- 2012
|
6.41 USD |
|
5 months ago
Jun 10, 2024
|
Sell 37.2 K USD
|
Kruh Willy
Director |
- 3738
|
9.94 USD |
|
5 months ago
Jun 10, 2024
|
Sell 17.7 K USD
|
Klein David Eric
Chief Executive Officer |
- 1779
|
9.94 USD |
|
5 months ago
Jun 10, 2024
|
Sell 447 USD
|
Hong Judy Eun Joo
Chief Financial Officer |
- 45
|
9.94 USD |
|
5 months ago
Jun 10, 2024
|
Sell 36.7 K USD
|
Yanofsky Theresa
Director |
- 3692
|
9.94 USD |
|
5 months ago
Jun 10, 2024
|
Sell 37.2 K USD
|
Mongeau Luc
Director |
- 3745
|
9.94 USD |
|
5 months ago
Jun 10, 2024
|
Sell 36.8 K USD
|
Lazzarato David Angelo
Director |
- 3707
|
9.94 USD |
|
10 months ago
Dec 29, 2023
|
Sell 24.7 K USD
|
Yanofsky Theresa
Director |
- 3697
|
6.68 USD |
|
10 months ago
Dec 29, 2023
|
Sell 24.8 K USD
|
Lazzarato David Angelo
Director |
- 3713
|
6.68 USD |
|
11 months ago
Nov 20, 2023
|
Sell 31.2 K USD
|
Lazzarato David Angelo
Director |
- 38502
|
0.81 USD |
|
11 months ago
Nov 20, 2023
|
Sell 31.1 K USD
|
Yanofsky Theresa
Director |
- 38344
|
0.81 USD |
|
11 months ago
Nov 20, 2023
|
Sell 15 K USD
|
SCHMELING JUDY
Director |
- 18481
|
0.81 USD |
|
1 year ago
Sep 01, 2023
|
Sell 27.7 K USD
|
Lazzarato David Angelo
Director |
- 38963
|
0.71 USD |
|
1 year ago
Sep 01, 2023
|
Sell 13.3 K USD
|
SCHMELING JUDY
Director |
- 18703
|
0.71 USD |
|
1 year ago
Sep 01, 2023
|
Sell 27.6 K USD
|
Yanofsky Theresa
Director |
- 38803
|
0.71 USD |
|
1 year ago
Jun 27, 2023
|
Sell 2.4 K USD
|
Lazzarato David Angelo
Director |
- 3872
|
0.62 USD |
|
1 year ago
Jun 27, 2023
|
Sell 12.2 K USD
|
Stewart Thomas Carlton
Chief Accounting Officer |
- 19667
|
0.62 USD |
|
1 year ago
Jun 30, 2023
|
Sell 9.76 K USD
|
Klein David Eric
Chief Executive Officer |
- 18775
|
0.52 USD |
|
1 year ago
Jun 27, 2023
|
Sell 2.39 K USD
|
Yanofsky Theresa
Director |
- 3856
|
0.62 USD |
|
1 year ago
Jun 27, 2023
|
Sell 1.15 K USD
|
SCHMELING JUDY
Director |
- 1859
|
0.62 USD |
|
1 year ago
Jun 30, 2023
|
Sell 565 USD
|
Hong Judy Eun Joo
Chief Financial Officer |
- 1087
|
0.52 USD |
|
1 year ago
Dec 28, 2022
|
Sell 11 K USD
|
Yanofsky Theresa
Director |
- 3717
|
2.97 USD |
|
1 year ago
Dec 28, 2022
|
Sell 11.1 K USD
|
Lazzarato David Angelo
Director |
- 3733
|
2.97 USD |
|
1 year ago
Dec 28, 2022
|
Sell 5.32 K USD
|
SCHMELING JUDY
Director |
- 1792
|
2.97 USD |
|
2 years ago
Jun 09, 2022
|
Sell 5.08 K USD
|
Hong Judy Eun Joo
Chief Financial Officer |
- 1021
|
4.98 USD |
|
2 years ago
Jun 09, 2022
|
Sell 1.4 K USD
|
Stewart Thomas Carlton
Chief Accounting Officer |
- 281
|
4.98 USD |
|
4 years ago
Aug 13, 2020
|
Sell 1.69 M USD
|
Shipley Tomas IV
See Remarks |
- 73333
|
23.1 USD |
|
4 years ago
Nov 13, 2020
|
Sell 2.72 M USD
|
Kovacevic Rade Nikola
President |
- 86666
|
31.38 USD |
|
4 years ago
Nov 12, 2020
|
Sell 4.75 M USD
|
Kovacevic Rade Nikola
President |
- 150000
|
31.65 USD |
|
4 years ago
Nov 13, 2020
|
Sell 1.82 K USD
|
Kovacevic Rade Nikola
President |
- 58
|
31.41 USD |
|
4 years ago
Nov 13, 2020
|
Sell 135 K USD
|
Kovacevic Rade Nikola
President |
- 4314
|
31.4 USD |
|
4 years ago
Nov 12, 2020
|
Sell 2.17 M USD
|
Shaer Phillip Stephen
Chief Legal Officer |
- 70000
|
31.03 USD |
|
19 years ago
Dec 28, 2004
|
Bought 10.7 K USD
|
BOGGS SCOTT M
Director |
+ 500
|
21.45 USD |
7. News
Canadian Gold Corp. Phase 3 Drilling at Tartan Mine Returns Multiple High-Grade Intercepts over Good Widths Extending Main Zone to the West Well Below Resource; Potential to Expand Resource Remains Excellent
Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - Canadian Gold Corp. (TSXV: CGC) ("Canadian Gold" or the "Company") is pleased to announce results from its Phase 3 Drill Program at the Tartan Mine, located near Flin Flon, Manitoba. Results in this news release have extended the high-grade mineralization along the western limits of the Main Zone (MZ) and continue to highlight a separate, longer-term opportunity of lower-grade bulk tonnage.
newsfilecorp.com
- 2 days ago
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zacks.com
- 3 days ago
Canopy Growth Corporation (CGC) Q2 2025 Earnings Call Transcript
Canopy Growth Corporation (CGC) Q2 2025 Earnings Call Transcript
seekingalpha.com
- 1 week ago
Canopy Growth Corporation (CGC) Reports Q2 Loss, Misses Revenue Estimates
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.38. This compares to loss of $1.80 per share a year ago.
zacks.com
- 1 week ago
Canopy Growth Reports Second Quarter Fiscal Year 2025 Financial Results
Storz & Bickel net revenue increased 32% year-over-year in Q2 FY2025 Continued growth across medical cannabis businesses, with net revenue increasing year-over-year by 16% in Canada and 12% in international markets Further improved balance sheet with early prepayment reducing senior secured term loan by US$100MM SMITHS FALLS, ON , Nov. 8, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial results for the second quarter ended September 30, 2024 ("Q2 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.
prnewswire.com
- 1 week ago
Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization
Amendment 3 – which would have legalized the recreational use of marijuana in the state's constitution – failed to receive the 60% support needed to pass under Florida law.
nypost.com
- 1 week ago
Cannabis stocks tank as Florida votes against recreational marijuana
Shares in cannabis stocks such as Trulieve Cannabis Corp. (CSE:TRUL), Curaleaf Hldgs Inc. (CSE:CURA, OTCQX:CURLF) and Verano Holdings Corp (CSE:VRNO, OTCQX:VRNOF) tanked after Florida rejected legalization of recreational marijuana. A ballot measure, known as Amendment 3, which would have allowed adults to possess up to three ounces of marijuana, failed to obtain the required 60% of support from voters yesterday.
proactiveinvestors.com
- 1 week ago
Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up
As the election approaches, Canadian cannabis stocks are capturing attention, especially with potential U.S. legalization developments on the horizon. The U.S. cannabis industry is booming, with projected growth reaching $41 billion by 2025. This massive market is appealing to Canadian companies seeking new revenue streams. Florida, in particular, is considering the legalization of recreational cannabis, which could unlock significant growth for Canadian cannabis companies with existing U.S. ties. If Florida joins the ranks of legal states, Canadian companies like Tilray, Canopy Growth, and Cronos Group could capitalize on this opportunity. These stocks are increasingly appealing to investors looking to benefit from potential changes in the U.S. market.
marijuanastocks.com
- 1 week ago
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zacks.com
- 2 weeks ago
3 Marijuana Stocks For Today's Trader
Marijuana stock investors are keeping a close eye on the sector. The reason for this is all that is occurring in the sector at this time. We have companies preparing to report earnings on top of the politics surrounding the promises of the presidential election. Politics can greatly impact trading depending on the circumstances. For instance, when a politician speaks in favor of legal cannabis, it has the potential to create a rise in trading.
marijuanastocks.com
- 2 weeks ago
Canopy Growth to Report Second Quarter Fiscal 2025 Financial Results on November 8, 2024
SMITHS FALLS, ON , Oct. 25, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the second quarter fiscal year 2025 ended September 30, 2024 before financial markets open on November 8, 2024. Following the release of its second quarter fiscal year 2025 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on November 8, 2024 at 10 AM Eastern Time.
prnewswire.com
- 3 weeks ago
Canopy Growth Corporation (CGC) Increases Despite Market Slip: Here's What You Need to Know
Canopy Growth Corporation (CGC) closed the most recent trading day at $5.04, moving +1.2% from the previous trading session.
zacks.com
- 3 weeks ago
8. Profile Summary
Canopy Growth Corporation CGC
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 491 M
Dividend Yield
0.00%
Description
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.
Contact
1 Hershey Drive, Smiths Falls, ON, K7A 0A8
https://www.canopygrowth.com
IPO Date
April 7, 2014
Employees
1029
Officers
Dr. Christelle Gedeon L.L.B., Ph.D.
Chief Legal Officer & Corporate Secretary
Mr. Jurgen Bickel
MD and Co-Founder of STORZ & BICKEL GmbH
Ms. Tara Rozalowsky
Chief Growth Officer & President of International
Ms. Jenny Brewer
Chief Human Resources Officer
Mr. Tyler Burns
Director of Investor Relations
Mr. Dave Paterson
President of Canada
Mr. David Eric Klein
Chief Executive Officer & Director
Jason Green
Head of Agriculture - Hemp Division
Ms. Judy Eunjoo Hong
Chief Financial Officer & Principal Accounting Officer